Cargando…

NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?

SIMPLE SUMMARY: Since its first description 35 years ago, the transcription factor NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) has been shown to be a key mediator of immune cell responses to inflammatory mediators, oxidative stress and genotoxic injury. Dysregulated NF-κB sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberti, Annabell, Chaffey, Laura Elizabeth, Greaves, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945680/ https://www.ncbi.nlm.nih.gov/pubmed/35336746 http://dx.doi.org/10.3390/biology11030372

Ejemplares similares

Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022)

NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017)

NF‐κB signaling in inflammation and cancer
por: Zhang, Tao, et al.
Publicado: (2021)

The complexity of NF-κB signaling in inflammation and cancer
por: Hoesel, Bastian, et al.
Publicado: (2013)

NF-κB: At the Borders of Autoimmunity and Inflammation
por: Barnabei, Laura, et al.
Publicado: (2021)

Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases
por: Murphy, Caitlin E., et al.
Publicado: (2022)

NF-κB signaling in tanycytes mediates inflammation-induced anorexia
por: Böttcher, Mareike, et al.
Publicado: (2020)

Suppression of NF-κB signaling by ECN in an arthritic model of inflammation
por: Khan, Amna, et al.
Publicado: (2022)

Negative regulatory NLRs mitigate inflammation via NF-κB pathway signaling in inflammatory bowel disease
por: Morrison, Holly A., et al.
Publicado: (2023)

AMPK-NF-κB Axis in the Photoreceptor Disorder during Retinal Inflammation
por: Kamoshita, Mamoru, et al.
Publicado: (2014)

NF-κB in inflammation and renal diseases
por: Zhang, Haisong, et al.
Publicado: (2015)

The TRAF6-NFκB signaling pathway in autoimmunity: not just inflammation
por: Thomas, Ranjeny
Publicado: (2005)

Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases
por: Oliver, Kathryn M, et al.
Publicado: (2009)

Cigarette Smoke Induced Airway Inflammation Is Independent of NF-κB Signalling
por: Rastrick, Joseph M. D., et al.
Publicado: (2013)

Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
por: Staal, Jens, et al.
Publicado: (2018)

Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation
por: Koganti, Raghuram, et al.
Publicado: (2022)

PDLIM1 inhibits NF-κB-mediated inflammatory signaling by sequestering the p65 subunit of NF-κB in the cytoplasm
por: Ono, Rumiko, et al.
Publicado: (2015)

Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
por: D’Ignazio, Laura, et al.
Publicado: (2017)

Drug repurposing candidates to treat core symptoms in autism spectrum disorder
por: Koch, Elise, et al.
Publicado: (2022)

The NF‐κB‐signalling pathway in mare's endometrium infiltrated with the inflammatory cells
por: Jasiński, Tomasz, et al.
Publicado: (2022)

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2022)

NF-κB Signalling in Glioblastoma
por: Soubannier, Vincent, et al.
Publicado: (2017)

Repurposing drugs to treat neurological diseases
por: Massey, T. H., et al.
Publicado: (2018)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Activation of Inflammation/NF-κB Signaling in Infants Born to Arsenic-Exposed Mothers
por: Fry, Rebecca C, et al.
Publicado: (2007)

Correction: Cigarette Smoke Induced Airway Inflammation Is Independent of NF-κB Signalling
por: Rastrick, Joseph M. D., et al.
Publicado: (2013)

Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
por: Cheng, Henry S., et al.
Publicado: (2014)

Roles of NF-κB Signaling in the Regulation of miRNAs Impacting on Inflammation in Cancer
por: Markopoulos, Georgios S., et al.
Publicado: (2018)

Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling
por: Hou, Yuanyuan, et al.
Publicado: (2021)

Retraction Note: Suppression of NF-κB signaling by ECN in an arthritic model of inflammation
por: Khan, Amna, et al.
Publicado: (2023)

NF-κB-mediated degradation of the co-activator RIP140 regulates inflammatory response and contributes to endotoxin tolerance
por: Ho, Ping-Chih, et al.
Publicado: (2012)

FKBP51 modulates steroid sensitivity and NFκB signalling: A novel anti‐inflammatory drug target
por: Kästle, Marc, et al.
Publicado: (2018)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

Expression of Wild-Type CFTR Suppresses NF-κB-Driven Inflammatory Signalling
por: Hunter, Mairi J., et al.
Publicado: (2010)

Regulation of NF-κB-Induced Inflammatory Signaling by Lipid Peroxidation-Derived Aldehydes
por: Yadav, Umesh C. S., et al.
Publicado: (2013)

Tolfenamic Acid Suppresses Inflammatory Stimuli-Mediated Activation of NF-κB Signaling
por: Shao, Hong Jun, et al.
Publicado: (2015)

Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling
por: Jarosz, Magdalena, et al.
Publicado: (2017)

NF-κB Signaling in Ovarian Cancer
por: Harrington, Brittney S., et al.
Publicado: (2019)

NF-κB Signaling in Gastric Cancer
por: Sokolova, Olga, et al.
Publicado: (2017)

NFκB signaling in alveolar rhabdomyosarcoma
por: Cleary, Megan M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7l8d9eolvbpmpo40q1d4mv2dk7